@article{a175bc31c5c84cd2ad00d878b49d46a2,
title = "Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity",
abstract = "Objective: Adenoviral vectored vaccines, with the appropriate gene insert, induce cellular and antibody responses against viruses, parasites and intracellular pathogens such as Mycobacterium tuberculosis. Here we explored their capacity to induce functional antibody responses to meningococcal transmembrane outer membrane proteins. Methods: Vectors expressing porin A and ferric enterobactin receptor A antigens were generated, and their immunogenicity assessed in mice using binding and bactericidal assays. Results: The viral vectors expressed the bacterial proteins in an in vitro cell-infection assay and, after immunisation of mice, induced higher titres (>10 5 end-point titre) and longer lasting (>32 weeks) transgene-specific antibody responses in vivo than did outer membrane vesicles containing the same antigens. However, bactericidal antibodies, which are the primary surrogate of protection against meningococcus, were undetectable, despite different designs to support the presentation of the protective B-cell epitopes. Conclusion: These results demonstrate that, while the transmembrane bacterial proteins expressed by the viral vector induced strong and persistent antigen-specific antibodies, this platform failed to induce bactericidal antibodies. The results suggest that conformation or post-translational modifications of bacterial outer membrane antigens produced in eukaryote cells might not result in presentation of the necessary epitopes for induction of functional antibodies. ",
keywords = "Adenovirus, Meningococcal disease, Meningococcus, Outer membrane protein, Porin, Vaccine, Vector",
author = "Leanne Marsay and Christina Dold and Paterson, {Gavin K.} and Yuko Yamaguchi and Jeremy Derrick and Hannah Chan and Feavers, {Ian M} and Maiden, {Martin C J} and David Wyllie and Hill, {Adrian V.} and Pollard, {Andrew J.} and Rollier, {Christine S.}",
note = "Funding Information: AJP is Chair of UK Dept. Health and Social Care's (DHSC) Joint Committee on Vaccination & Immunisation (JCVI), and is a member of the WHO's SAGE. AJP is an NIHR Senior Investigator. The views expressed in this article do not necessarily represent the views of DHSC, JCVI, NIHR or WHO. MS is currently supported via salary awards from the BC Children's Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by Pfizer, Merck, Seqirus, Sanofi-Pasteur, VBI Vaccines and GlaxoSmithKline. All funds have been paid to his institute, and he has not received any personal payments. MM undertakes occasional consultancy work for Pfizer, GSK and Novartis. IF was an employee at NIBSC, a centre of the Medicines and Healthcare products Regulatory Agency. CR, CD, LM, DW, AVSH, AJP are named inventors on a patent application in the field of meningococcal vaccine. AJP waives all his rights to any patent. AVSH is a co-founder of and consultant to Vaccitech and is named as an inventor on a patent covering design and use of ChAdOx1-vectored vaccines. GKP, YY, HC, JPD declare no conflict of interest. The sponsors had no role in the design, execution, interpretation, or writing of the study. The views expressed in this publication are those of the authors. Funding Information: This work was supported by a project grant from Meningitis UK (now MeningitisNow), Wellcome Trust, Innovation Schemes (Ref 082102/Z/07/A and 091634/Z/10/Z), and by the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom, Vaccine theme. The funding sources had no involvement in study design, conduct of research, preparation of the article nor in the decision to submit for publication. Publisher Copyright: {\textcopyright} 2022",
year = "2022",
month = may,
day = "1",
doi = "10.1016/j.jinf.2022.02.032",
language = "English",
volume = "84",
pages = "658--667",
journal = "Journal Of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Co. Ltd",
number = "5",
}